BTIG Keeps a Buy Rating on SeaSpine Holdings (SPNE)

BTIG analyst Ryan Zimmerman maintained a Buy rating on SeaSpine Holdings (SPNEResearch Report) today and set a price target of $14.00. The company’s shares closed last Friday at $7.45.

According to, Zimmerman is a 4-star analyst with an average return of 3.8% and a 44.5% success rate. Zimmerman covers the Healthcare sector, focusing on stocks such as Tactile Systems Technology, Staar Surgical Company, and Zimmer Biomet Holdings.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for SeaSpine Holdings with a $19.83 average price target, which is a 166.2% upside from current levels. In a report issued on April 2, SunTrust Robinson also initiated coverage with a Buy rating on the stock with a $15.00 price target.

See today’s analyst top recommended stocks >>

Based on SeaSpine Holdings’ latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $43.74 million and GAAP net loss of $8.59 million. In comparison, last year the company earned revenue of $38.03 million and had a GAAP net loss of $9.53 million.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

SeaSpine Holdings Corp. is a medical technology company, which focuses on design, development and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. It has a comprehensive portfolio of orthobiologics and spinal fusion hardware solutions to meet the varying combinations of products that neurosurgeons and orthopedic spine surgeons need to perform fusion procedures on the lumbar, thoracic and cervical spine. The company was founded on February 12, 2015 and is headquartered in Carlsbad, CA.